Review



anti il 6 capture antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems anti il 6 capture antibody
    Anti Il 6 Capture Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 76 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+il+6+capture+antibody/pmc13078997-261-19-22?v=R%26D+Systems
    Average 95 stars, based on 76 article reviews
    anti il 6 capture antibody - by Bioz Stars, 2026-08
    95/100 stars

    Images



    Similar Products

    91
    Sino Biological anti ifn γ capture antibodies
    A: Construction of the recombinant phage displaying the <t>anti-IFN-γ</t> antibody. Schematic diagram of the recombinant phage plasmid. B: PD–IPCR results of M13KO7-IFN-HuZAF phage binding with the c-MYC antibody. The wild-type M13K07 phage was used as a negative control. (** p < 0.0001, n = 3). C: Western blot analysis of M13KO7-IFN-HuZAF phage binding to the c-MYC antibody. The wild-type M13K07 phage was used as a negative control.
    Anti Ifn γ Capture Antibodies, supplied by Sino Biological, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+il+6+capture+antibody/pmc11755140-86-7-12?v=Sino+Biological
    Average 91 stars, based on 1 article reviews
    anti ifn γ capture antibodies - by Bioz Stars, 2026-08
    91/100 stars
      Buy from Supplier

    95
    R&D Systems anti il 6 capture antibody
    A: Construction of the recombinant phage displaying the <t>anti-IFN-γ</t> antibody. Schematic diagram of the recombinant phage plasmid. B: PD–IPCR results of M13KO7-IFN-HuZAF phage binding with the c-MYC antibody. The wild-type M13K07 phage was used as a negative control. (** p < 0.0001, n = 3). C: Western blot analysis of M13KO7-IFN-HuZAF phage binding to the c-MYC antibody. The wild-type M13K07 phage was used as a negative control.
    Anti Il 6 Capture Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+il+6+capture+antibody/pmc13078997-261-19-22?v=R%26D+Systems
    Average 95 stars, based on 1 article reviews
    anti il 6 capture antibody - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    94
    Sino Biological il 6 capture antibody
    A: Construction of the recombinant phage displaying the <t>anti-IFN-γ</t> antibody. Schematic diagram of the recombinant phage plasmid. B: PD–IPCR results of M13KO7-IFN-HuZAF phage binding with the c-MYC antibody. The wild-type M13K07 phage was used as a negative control. (** p < 0.0001, n = 3). C: Western blot analysis of M13KO7-IFN-HuZAF phage binding to the c-MYC antibody. The wild-type M13K07 phage was used as a negative control.
    Il 6 Capture Antibody, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+il+6+capture+antibody/pm40356265-200-0-26?v=Sino+Biological
    Average 94 stars, based on 1 article reviews
    il 6 capture antibody - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    96
    HyTest monoclonal anti human il 6 capture antibody
    A: Construction of the recombinant phage displaying the <t>anti-IFN-γ</t> antibody. Schematic diagram of the recombinant phage plasmid. B: PD–IPCR results of M13KO7-IFN-HuZAF phage binding with the c-MYC antibody. The wild-type M13K07 phage was used as a negative control. (** p < 0.0001, n = 3). C: Western blot analysis of M13KO7-IFN-HuZAF phage binding to the c-MYC antibody. The wild-type M13K07 phage was used as a negative control.
    Monoclonal Anti Human Il 6 Capture Antibody, supplied by HyTest, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+il+6+capture+antibody/pmc11983360-2-6-20?v=HyTest
    Average 96 stars, based on 1 article reviews
    monoclonal anti human il 6 capture antibody - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    R&D Systems mouse anti human il 6 capture antibody
    A: Construction of the recombinant phage displaying the <t>anti-IFN-γ</t> antibody. Schematic diagram of the recombinant phage plasmid. B: PD–IPCR results of M13KO7-IFN-HuZAF phage binding with the c-MYC antibody. The wild-type M13K07 phage was used as a negative control. (** p < 0.0001, n = 3). C: Western blot analysis of M13KO7-IFN-HuZAF phage binding to the c-MYC antibody. The wild-type M13K07 phage was used as a negative control.
    Mouse Anti Human Il 6 Capture Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+il+6+capture+antibody/pmc11483399__ao4c08041_si_001-20-0-12?v=R%26D+Systems
    Average 96 stars, based on 1 article reviews
    mouse anti human il 6 capture antibody - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    93
    R&D Systems anti mouse il 6 capture antibody
    A: Construction of the recombinant phage displaying the <t>anti-IFN-γ</t> antibody. Schematic diagram of the recombinant phage plasmid. B: PD–IPCR results of M13KO7-IFN-HuZAF phage binding with the c-MYC antibody. The wild-type M13K07 phage was used as a negative control. (** p < 0.0001, n = 3). C: Western blot analysis of M13KO7-IFN-HuZAF phage binding to the c-MYC antibody. The wild-type M13K07 phage was used as a negative control.
    Anti Mouse Il 6 Capture Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+il+6+capture+antibody/pm38493914-97-73-90?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    anti mouse il 6 capture antibody - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    90
    Becton Dickinson rat anti-human il-6 capture antibody
    A: Construction of the recombinant phage displaying the <t>anti-IFN-γ</t> antibody. Schematic diagram of the recombinant phage plasmid. B: PD–IPCR results of M13KO7-IFN-HuZAF phage binding with the c-MYC antibody. The wild-type M13K07 phage was used as a negative control. (** p < 0.0001, n = 3). C: Western blot analysis of M13KO7-IFN-HuZAF phage binding to the c-MYC antibody. The wild-type M13K07 phage was used as a negative control.
    Rat Anti Human Il 6 Capture Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+il+6+capture+antibody/pm38148453-39-16-21?v=Becton+Dickinson
    Average 90 stars, based on 1 article reviews
    rat anti-human il-6 capture antibody - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    Image Search Results


    A: Construction of the recombinant phage displaying the anti-IFN-γ antibody. Schematic diagram of the recombinant phage plasmid. B: PD–IPCR results of M13KO7-IFN-HuZAF phage binding with the c-MYC antibody. The wild-type M13K07 phage was used as a negative control. (** p < 0.0001, n = 3). C: Western blot analysis of M13KO7-IFN-HuZAF phage binding to the c-MYC antibody. The wild-type M13K07 phage was used as a negative control.

    Journal: ACS Omega

    Article Title: Phage Display-Mediated Immuno-Multiplex Quantitative PCR for the Simultaneous Quantification of IFN-γ and IL-6

    doi: 10.1021/acsomega.4c09624

    Figure Lengend Snippet: A: Construction of the recombinant phage displaying the anti-IFN-γ antibody. Schematic diagram of the recombinant phage plasmid. B: PD–IPCR results of M13KO7-IFN-HuZAF phage binding with the c-MYC antibody. The wild-type M13K07 phage was used as a negative control. (** p < 0.0001, n = 3). C: Western blot analysis of M13KO7-IFN-HuZAF phage binding to the c-MYC antibody. The wild-type M13K07 phage was used as a negative control.

    Article Snippet: First, 50 μL each of anti-IL-6 and anti-IFN-γ capture antibodies (1:250 dilution; Sino Biological, Beijing, China; Cat. # 10395-MM14) were added to each well of the ELISA 96-well plate overnight, and the plate was blocked with 2% BSA in PBST for 2 h. One hundred microliters of gradient-diluted IL-6 and IFN-γ protein standards (CLOUD-CLONE CORP, Wuhan, China) were added to each well, and the plate was incubated at 37 °C for 2 h. Each well was blocked with 200 μL of M13KO7-blocking phage at a titer of 1 × 10 9 copies/μL for 2 h. One hundred microliters of M13KO7-blocking phage at a concentration of 5 × 10 7 copies/μL each was added.

    Techniques: Recombinant, Plasmid Preparation, Binding Assay, Negative Control, Western Blot

    A: Specificity of PD–IMPCR. B: Standard curve of qPCR amplification efficiency obtained with 10-fold serial dilutions of the recombinant phage, plotted with the quantification cycle (Cq) and the log10 phage concentration. The regression parameters are shown on the left. C: Standard curve of PD–IMPCR for detecting IFN-γ. D: Results of the recovery assay. E: Stability of the recombinant phage. F: ELISA results compared with the PD–IMPCR results.

    Journal: ACS Omega

    Article Title: Phage Display-Mediated Immuno-Multiplex Quantitative PCR for the Simultaneous Quantification of IFN-γ and IL-6

    doi: 10.1021/acsomega.4c09624

    Figure Lengend Snippet: A: Specificity of PD–IMPCR. B: Standard curve of qPCR amplification efficiency obtained with 10-fold serial dilutions of the recombinant phage, plotted with the quantification cycle (Cq) and the log10 phage concentration. The regression parameters are shown on the left. C: Standard curve of PD–IMPCR for detecting IFN-γ. D: Results of the recovery assay. E: Stability of the recombinant phage. F: ELISA results compared with the PD–IMPCR results.

    Article Snippet: First, 50 μL each of anti-IL-6 and anti-IFN-γ capture antibodies (1:250 dilution; Sino Biological, Beijing, China; Cat. # 10395-MM14) were added to each well of the ELISA 96-well plate overnight, and the plate was blocked with 2% BSA in PBST for 2 h. One hundred microliters of gradient-diluted IL-6 and IFN-γ protein standards (CLOUD-CLONE CORP, Wuhan, China) were added to each well, and the plate was incubated at 37 °C for 2 h. Each well was blocked with 200 μL of M13KO7-blocking phage at a titer of 1 × 10 9 copies/μL for 2 h. One hundred microliters of M13KO7-blocking phage at a concentration of 5 × 10 7 copies/μL each was added.

    Techniques: Amplification, Recombinant, Concentration Assay, Enzyme-linked Immunosorbent Assay

    Primers used in this Study

    Journal: ACS Omega

    Article Title: Phage Display-Mediated Immuno-Multiplex Quantitative PCR for the Simultaneous Quantification of IFN-γ and IL-6

    doi: 10.1021/acsomega.4c09624

    Figure Lengend Snippet: Primers used in this Study

    Article Snippet: First, 50 μL each of anti-IL-6 and anti-IFN-γ capture antibodies (1:250 dilution; Sino Biological, Beijing, China; Cat. # 10395-MM14) were added to each well of the ELISA 96-well plate overnight, and the plate was blocked with 2% BSA in PBST for 2 h. One hundred microliters of gradient-diluted IL-6 and IFN-γ protein standards (CLOUD-CLONE CORP, Wuhan, China) were added to each well, and the plate was incubated at 37 °C for 2 h. Each well was blocked with 200 μL of M13KO7-blocking phage at a titer of 1 × 10 9 copies/μL for 2 h. One hundred microliters of M13KO7-blocking phage at a concentration of 5 × 10 7 copies/μL each was added.

    Techniques: Sequencing, Recombinant, SYBR Green Assay, Blocking Assay